Literature DB >> 2431843

Symptomatic recurrences of carcinoma of the rectum and sigmoid. The influence of radiotherapy on the quality of life.

P Pacini, L Cionini, L Pirtoli, S Ciatto, E Tucci, L Sebaste.   

Abstract

One hundred forty-three patients irradiated for locoregional recurrences after curative surgery for cancer of the rectum and sigmoid were studied retrospectively. An analysis was made of the symptomatic response and survival in the total series and in three subgroups treated with different dose levels (40 Gy or lower, between 40 and 50 Gy, 50 Gy or higher). The symptom-free period was calculated as percent of the overall survival. Symptomatic control was obtained in 80.4 percent of the cases, and the crude patient survival rate was 17.5 percent at two years. No significant difference was found in the three subgroups treated with different dose levels. The cumulative time/patient asymptomatic periods in the total series and in the three subgroups were 31.5, 30.2, 31.8, and 31.9 percent respectively, of the survival period.

Entities:  

Mesh:

Year:  1986        PMID: 2431843     DOI: 10.1007/bf02555365

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  9 in total

1.  A phase I trial of S-1 with concurrent radiotherapy in patients with locally recurrent rectal cancer.

Authors:  Hitoshi Wada; Kenji Nemoto; Takuma Nomiya; Misako Murakami; Motohisa Suzuki; Yuuki Kuroda; Mayumi Ichikawa; Ibuki Ota; Yasuhito Hagiwara; Hisanori Ariga; Ken Takeda; Kenji Takai; Keisuke Fujimoto; Masahiro Kenjo; Kazuhiko Ogawa
Journal:  Int J Clin Oncol       Date:  2012-02-09       Impact factor: 3.402

Review 2.  Surveillance of patients following surgery with curative intent for colorectal cancer.

Authors:  Steven Gan; Katherine Wilson; Paul Hollington
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

3.  Three-dimensional conformal radiotherapy combined with FOLFOX4 chemotherapy for unresectable recurrent rectal cancer.

Authors:  Jian-Bin Hu; Xiao-Nan Sun; Qi-Chu Yang; Jing Xu; Qi Wang; Chao He
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

4.  Focal dose escalation using FDG-PET-guided intensity-modulated radiation therapy boost for postoperative local recurrent rectal cancer: a planning study with comparison of DVH and NTCP.

Authors:  Keiichi Jingu; Hisanori Ariga; Tomohiro Kaneta; Yoshihiro Takai; Ken Takeda; Lindel Katja; Kakutaro Narazaki; Takahiro Metoki; Keisuke Fujimoto; Rei Umezawa; Yoshihiro Ogawa; Kenji Nemoto; Masashi Koto; Masatoshi Mitsuya; Naruhiro Matsufuji; Shoki Takahashi; Shogo Yamada
Journal:  BMC Cancer       Date:  2010-04-07       Impact factor: 4.430

Review 5.  Radiation treatment for rectal cancer.

Authors:  B J Cummings
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

Review 6.  Primary therapy of carcinoma of the large bowel.

Authors:  V W Fazio; J J Tjandra
Journal:  World J Surg       Date:  1991 Sep-Oct       Impact factor: 3.352

7.  CT-guided radioactive seed implantation for recurrent rectal carcinoma after multiple therapy.

Authors:  Jun Jie Wang; Hui Shu Yuan; Jin Na Li; Yu Liang Jiang; Su Qing Tian; Rui Jie Yang
Journal:  Med Oncol       Date:  2009-05-05       Impact factor: 3.064

8.  [Results of the treatment with fast neutrons (d.T 13 MeV) in recurrent rectal carcinoma].

Authors:  F J Prott; R Pötter; P Preusser; O Micke; A Schouwink; N Willich
Journal:  Strahlenther Onkol       Date:  1997-06       Impact factor: 4.033

Review 9.  Palliative pelvic radiotherapy of symptomatic incurable rectal cancer - a systematic review.

Authors:  Marte Grønlie Cameron; Christian Kersten; Ingvild Vistad; Sophie Fosså; Marianne Grønlie Guren
Journal:  Acta Oncol       Date:  2013-11-06       Impact factor: 4.089

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.